1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Gastric Cancer Global Clinical Trials Review, H2, 2015

Gastric Cancer Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 179 pages

Gastric Cancer Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Gastric Cancer Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Gastric Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastric Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastric Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Gastric Cancer 25
Subjects Recruited Over a Period of Time 36
Clinical Trials by Sponsor Type 37
Prominent Sponsors 38
Top Companies Participating in Gastric Cancer Therapeutics Clinical Trials 39
Prominent Drugs 40
Latest Clinical Trials News on Gastric Cancer 41
May 29, 2015: Spectrum Pharmaceuticals Highlights Abstract of Clinical Data For Folotyn at the 2015 ASCO Annual Meeting 41
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Sanofi 48
Clinical Trial Overview of Sanofi 48
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
AstraZeneca Plc 56
Clinical Trial Overview of AstraZeneca Plc 56
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
Pfizer Inc. 61
Clinical Trial Overview of Pfizer Inc. 61
Eli Lilly and Company 63
Clinical Trial Overview of Eli Lilly and Company 63
Bristol-Myers Squibb Company 65
Clinical Trial Overview of Bristol-Myers Squibb Company 65
GlaxoSmithKline Plc 67
Clinical Trial Overview of GlaxoSmithKline Plc 67
Amgen Inc. 69
Clinical Trial Overview of Amgen Inc. 69
Clinical Trial Overview of Top Institutes / Government 71
Asan Medical Center 71
Clinical Trial Overview of Asan Medical Center 71
Memorial Sloan Kettering Cancer Center 73
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 73
Osaka Gastrointestinal Cancer Chemotherapy Study Group 75
Clinical Trial Overview of Osaka Gastrointestinal Cancer Chemotherapy Study Group 75
FUDAN University 78
Clinical Trial Overview of FUDAN University 78
National Cancer Center 80
Clinical Trial Overview of National Cancer Center 80
European Organization for Research and Treatment of Cancer 82
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 82
Japan Clinical Oncology Group 83
Clinical Trial Overview of Japan Clinical Oncology Group 83
Samsung Medical Center 85
Clinical Trial Overview of Samsung Medical Center 85
Seoul National University Hospital 87
Clinical Trial Overview of Seoul National University Hospital 87
Five Key Clinical Profiles 88
Appendix 176
Abbreviations 176
Definitions 176
Research Methodology 177
Secondary Research 177
About GlobalData 178
Contact Us 178
Disclaimer 178
Source 179

List of Tables
Gastric Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Gastric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Gastric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Gastric Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Gastric Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Gastric Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Gastric Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Gastric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Gastric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Gastric Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Gastric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Gastric Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Gastric Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Gastric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Gastric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Gastric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Gastric Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Gastric Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Gastric Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 29
Gastric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 36
Gastric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 37
Gastric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 38
Gastric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 39
Gastric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 40
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 42
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 48
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 53
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 56
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 61
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 63
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 65
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 67
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 69
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 71
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 73
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Gastrointestinal Cancer Chemotherapy Study Group, 2015* 75
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 78
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015* 80
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 82
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2015* 83
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 85
Gastric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 87

List of Figures
Gastric Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Gastric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Gastric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Gastric Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Gastric Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Gastric Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Gastric Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Gastric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Gastric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Gastric Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Gastric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Gastric Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Gastric Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Gastric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Gastric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Gastric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Gastric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 36
Gastric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 37
Gastric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 38
Gastric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 39
Gastric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 40
GlobalData Methodology 177

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.